Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Capital Expenditures Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -0.66%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -14.20%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 12.42%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 9.94%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 10.89%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 11.78%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 6.38%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 12.81%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 9.52%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -9.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.14%
Mar 31, 2026 -45.47%
Jun 30, 2024 -20.33%
Mar 31, 2024 3.23%
Dec 31, 2023 77.58%
Sep 30, 2023 -64.84%
Jun 30, 2023 -1.61%
Mar 31, 2023 9.74%
Dec 31, 2022 -29.25%
Dec 31, 2021 -53.47%
Sep 30, 2021 -12.73%
Jun 30, 2021 -12.09%
Mar 31, 2021 -44.97%
Dec 31, 2020 -26.38%